New guideline on neurogenic bladder disorders published in Germany

25

May 2020

The German Society for Neurology (DGN) has published a new version of the S1 guideline "Diagnostics and therapy of neurogenic bladder disorders." It is valid until January 2025.

The authors recommend the following diagnostic cascade:

  • Anamnesis
  • Neurological and urological examination, if necessary, gynecological examination
  • Bladder diary for at least three full days
  • Urine sediment examination (medium jet or better catheter urine)
  • Residual urine measurement (sonographically or by single-use catheterization)
  • Urine flow measurement (Uroflow)
  • (Video) urodynamics (so-called bladder pressure measurement) with pelvic floor electromyography (EMG)
  • Urethrocystoscopy and urinary bladder cytology
  • Kidney sonography
  • Creatinine, urea, possibly 24-hour creatinine clearance
  • Lasix or stress isotope nephrogram.

If vesicorenal reflux has already occurred, it is advisable to use these procedures to document the initial findings. Based on these steps, a diagnosis can usually be made. Differential diagnosis should also distinguish psychiatric and psychosomatic diseases.

The guideline in German can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

09

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more